Dealing with a new diagnosis or confusing lab numbers? Talk with people who have been there. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data
← All Conditions (3,135) / Prostate (BPH), Bladder & Urinary Tract

Prostate (BPH), Bladder & Urinary Tract (128 Condition Guides)

Benign prostatic hyperplasia (BPH), urinary tract infections, overactive bladder, and kidney stones.

Interactive MyChart Lab & Cuff Translator • Lab Bell-Curve “Normal” vs. Physiological Optimal

Why Your Portal Says “Normal” When You Still Feel Awful: Enter Your Number

Quest and LabCorp “Normal” ranges are 95% population bell curves—not physiological optimums. Select a marker and type your result below:

3-Zone Clinical Cutoff Audit • Serum Ferritin (Iron Storage)

18 ng/mL = Marked "Normal" by Lab, Yet Clinically Depleted (< 30–50 ng/mL)

Default Sample: 18 ng/mL
Zone 1 • Clinical Cutoff
< 15 ng/mL • Overt Deficiency
< 15 ng/mL (Absolute Depletion)
Zone 2 • Portal “Normal” Gray Zone
15–49 ng/mL • "Normal" Yet Depleted
15–150 ng/mL (Quest/LabCorp Bell Curve)
Zone 3 • Physiological Optimal
50–100 ng/mL • Clinical Optimal
50–100 ng/mL (Physiological Optimal)
What This Number Means in Plain English

Commercial labs only flag Ferritin below 15 ng/mL, but clinical trials confirm fatigue, restless legs, diffuse telogen hair shedding, and impaired T4-to-T3 thyroid conversion begin whenever Ferritin drops below 30–50 ng/mL.

Action Plan: Take 25–28 mg elemental Iron Bisglycinate on alternate mornings (Mon/Wed/Fri) with Vitamin C to bypass the 24-hour hepcidin block, then re-test in 8–12 weeks.

⚠ Lab Assay & Cuff False-Alarm Check

Acute inflammation, viral illness, or fatty liver artificially elevates Ferritin (it is an acute-phase reactant). Always pair Ferritin with Fasting Transferrin Saturation (TSAT) and hs-CRP.

Specialty Directory

Prostate (BPH), Bladder & Urinary Tract Guides (128)

Clear Filter × Page 2 of 4

Dribbling of urine

Also called: Water • Amniotic

Dribbling of urine (ICD-10-CM N39.43) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Duplicated urinary tract

Also called: Urinate

Duplicated urinary tract (ICD-10-CM Q64.9) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Endometritis

Endometritis (ICD-10-CM N71.9) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Enlarged Prostate (BPH)

Also called: Benign prostatic hyperplasia

The prostate is a gland in the male reproductive system. It lies just below the bladder. It makes fluid that is part of semen. What is an enlarged prostate (BPH)? An enlarged prostate is when your prostate gland becomes larger than normal. It's also called benign prostatic hyperplasia or BPH for short. Benign means not cancer. And hyperplasia means too much cell growth. BPH isn't cancer and it doesn't increase your risk of getting prostate cancer. Usually, the prostate gland continues to grow during adult life. That's why BPH is the most common prostate condition in people over age 50.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Epididymitis

Designated in federal medical registries as N45.1, Epididymitis falls under Urology & Prostate management, where urinalysis/urine culture [Epididymitis N45.1] establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Excessive male-pattern hair (hirsutism)

Also called: Hirsutism

Excessive male-pattern hair (hirsutism) (ICD-10-CM L68.0) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Fragrance-free ceramide barrier repair + targeted topical retinoid, anti-inflammatory, or antimicrobial regimen

Focal segmental glomerulosclerosis (FSGS)

Also called: Glomerulosclerosis - Focal segmental • Segmental

Focal segmental glomerulosclerosis (FSGS)—coded clinically as N26.9 across Urology & Prostate guidelines—combines urinalysis/urine culture [Focal segmental glomerulosclerosis (FSGS) N26.9] with structured follow-up of IPSS Urinary Symptom in Focal segmental glomerulosclerosis (FSGS) (N26.9: Score) (0 – 7 (mild symptoms) (N26.9)).

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Galactorrhea

Galactorrhea (ICD-10-CM N64.3) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Genitourinary disorder

Genitourinary disorder (ICD-10-CM N20.4) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Glomerulonephritis (GN)

Glomerulonephritis (GN) (ICD-10-CM N05.9) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Glomerulonephritis - chronic membranous

Glomerulonephritis - chronic membranous (ICD-10-CM N03.2) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Glomerulonephritis - membranoproliferative (MPGN)

Also called: Glomerulonephritis - membranoproliferative

Glomerulonephritis - membranoproliferative (MPGN) (ICD-10-CM N05.5) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Glomerulonephritis - mesangial proliferative (MPGN)

Also called: Glomerulonephritis - mesangial proliferative

Glomerulonephritis - mesangial proliferative (MPGN)—coded clinically as N05.3 across Urology & Prostate guidelines—combines hydration citrate protocols [Glomerulonephritis - mesangial proliferative (MPGN) N05.3] with structured follow-up of Urinalysis & Post-Void in Glomerulonephritis - mesangial proliferative (MPGN) (N05.3: Residual (PVR)) (Negative leukocyte/nitrite; PVR < 50 mL (N05.3)).

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Glomerulonephritis - post-infectious

Glomerulonephritis - post-infectious (ICD-10-CM N05.9) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Glomerulonephritis - rapidly progressive (RPGN)

Also called: Glomerulonephritis - rapidly progressive

Glomerulonephritis - rapidly progressive (RPGN)—coded clinically as N01.9 across Urology & Prostate guidelines—combines 5-alpha-reductase volume reduction [Glomerulonephritis - rapidly progressive (RPGN) N01.9] with structured follow-up of Urinalysis & Post-Void in Glomerulonephritis - rapidly progressive (RPGN) (N01.9: Residual (PVR)) (Negative leukocyte/nitrite; PVR < 50 mL (N01.9)).

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Granulomatous prostatitis

Granulomatous prostatitis (ICD-10-CM N41.4) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Gynecomastia

Gynecomastia (ICD-10-CM N62) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Herbal Medicine

Also called: Botanicals • Phytotherapy

An herb is a plant or plant part used for its scent, flavor, or therapeutic properties. Herbal medicines are one type of dietary supplement. They are sold as tablets, capsules, powders, teas, extracts, and fresh or dried plants. People use herbal medicines to try to maintain or improve their health. Many people believe that products labeled "natural" are always safe and good for them. This is not necessarily true. Herbal medicines do not have to go through the testing that drugs do. Some herbs, such as comfrey and ephedra, can cause serious harm. Some herbs can interact with prescription or over-the-counter medicines.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Hydrocele

Hydrocele (ICD-10-CM N43.3) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Hydronephrosis

Hydronephrosis (ICD-10-CM N13.30) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Incontinence without sensory awareness

Incontinence without sensory awareness (ICD-10-CM N39.42) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Indoor Air Pollution

We usually think of air pollution as being outdoors, but the air in your house or office could also be polluted. Sources of indoor pollution include: Mold and pollen Tobacco smoke Household products and pesticides Gases such as radon and carbon monoxide Materials used in the building such as asbestos, formaldehyde and lead Sometimes a group of people have symptoms that seem to be linked to time spent in a certain building. There may be a specific cause, such as Legionnaire's disease. Sometimes the cause of the illness cannot be found. This is known as sick building syndrome. Usually indoor air quality problems only cause discomfort.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Interstitial Cystitis

Also called: Bladder pain syndrome • PBS • Painful bladder syndrome

Interstitial cystitis (IC) is a condition that causes discomfort or pain in the bladder and a need to urinate frequently and urgently. It is far more common in women than in men. The symptoms vary from person to person. Some people may have pain without urgency or frequency. Others have urgency and frequency without pain. Women's symptoms often get worse during their periods. They may also have pain with sexual intercourse. The cause of IC isn't known. There is no one test to tell if you have it. Doctors often run tests to rule out other possible causes of symptoms. There is no cure for IC, but treatments can help most people feel better.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Interstitial cystitis (chronic) with hematuria

Interstitial cystitis (chronic) with hematuria (ICD-10-CM N30.11) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Interstitial cystitis (chronic) without hematuria

Interstitial cystitis (chronic) without hematuria (ICD-10-CM N30.10) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Interstitial nephritis

Interstitial nephritis (ICD-10-CM N12) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Interstitial nephritis - acute

Interstitial nephritis - acute (ICD-10-CM N10) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Interstitial nephritis - chronic

Interstitial nephritis - chronic (ICD-10-CM N11.9) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Irradiation cystitis with hematuria

Irradiation cystitis with hematuria (ICD-10-CM N30.41) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Irradiation cystitis without hematuria

Irradiation cystitis without hematuria (ICD-10-CM N30.40) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Kidney Stones

Also called: Nephrolithiasis • Nephric • Nephron

A kidney stone is a solid piece of material that forms in the kidney from substances in the urine. It may be as small as a grain of sand or as large as a pearl. Most kidney stones pass out of the body without help from a doctor. But sometimes a stone will not go away. It may get stuck in the urinary tract, block the flow of urine and cause great pain. The following may be signs of kidney stones that need a doctor's help: Extreme pain in your back or side that will not go away Blood in your urine Fever and chills Vomiting Urine that smells bad or looks cloudy A burning feeling when you urinate Your doctor will diagnose a kidney stone with urine, blood, and imaging tests.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Laboratory Tests

Laboratory tests check a sample of your blood, urine, or body tissues. A technician or your doctor analyzes the test samples to see if your results fall within the normal range. The tests use a range because what is normal differs from person to person. Many factors affect test results. These include: Your sex, age and race What you eat and drink Medicines you take How well you followed pre-test instructions Your doctor may also compare your results to results from previous tests. Laboratory tests are often part of a routine checkup to look for changes in your health. They also help doctors diagnose medical conditions, plan or evaluate treatments, and monitor diseases.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Leukemia cutis

Also called: Cutis • Dermal

Leukemia cutis—coded clinically as C79.2 across Urology & Prostate guidelines—combines urinalysis/urine culture [Leukemia cutis C79.2] with structured follow-up of IPSS Urinary Symptom in Leukemia cutis (C79.2: Score) (0 – 7 (mild symptoms) (C79.2)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Lymphocytoma cutis

Also called: Cutis • Dermal

Lymphocytoma cutis—coded clinically as L98.8 across Urology & Prostate guidelines—combines IPSS symptom scoring [Lymphocytoma cutis L98.8] with structured follow-up of Total PSA & in Lymphocytoma cutis (L98.8: Serum Creatinine/eGFR) (Age-specific PSA; eGFR > 75 mL/min (L98.8)).

First-Line Fix: Fragrance-free ceramide barrier repair + targeted topical retinoid, anti-inflammatory, or antimicrobial regimen

Mastitis

Mastitis (ICD-10-CM N61.0) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy

Minimal change disease (MCD)

Also called: Glomerulonephritis - minimal change

Minimal change disease (MCD) (ICD-10-CM N05.0) is evaluated within Prostate (BPH), Bladder & Urinary Tract using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Targeted renal/urologic or gynecologic protocol, hydration balance, and guideline-directed therapy
Connected Clinical Ecosystem • Medications, Supplements & Specialists

Go From Diagnosis to Treatment: Connected Flagship Guides

Prescription Medications (/meds)

FDA DailyMed & NADAC Cash Price Guides

Decode tablet imprints, IR vs. ER stomach side effects, Rule-of-6 dose response curves, and $3–$9 generic cash prices.

Dietary Supplements (/supplements)

NIH ODS & Elemental Label Math Guides

Separate human RCT outcomes from social media hype—with elemental vs. compound weight decoders and serum 25(OH)D targets.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Compare U.S. specialists by real CMS Medicare Part B procedure volume, verified Google patient reviews, and accepted PPO/Medicare plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

Which diagnostic lab ranges and guidelines govern Prostate (BPH), Bladder & Urinary Tract on dotMD.com?

dotMD.com maps Prostate (BPH), Bladder & Urinary Tract against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

Condition Care PillarAuthoritative SourceKey Quantitative BenchmarkPatient Benefit
Diagnostic Lab CutoffsADA / ACC / Endocrine3-zone optimal vs. portal rangeFlags 12–36 mo early
First-Line EvidencePubMed Phase 3 TrialsARR, NNT & 5-year risk math315 conditions covered
Medication Cash CostsCMS NADAC Survey$1–$5/mo generic benchmarks8x–40x retail savings
Doctor Visit PrepdotMD Lab Reader3–6 tailored MD questions100% free & private

How should patients prepare lab numbers and questions for a Prostate (BPH), Bladder & Urinary Tract visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee